Adverse reactions to drugs: In vitro studies with isolated cells

Inflammation Research

Volumn 53, Issue SUPPL. 2, 2004, Pages

  Ennis, M ^a   Nehring, E ^b   Schneider, C ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Adverse drug reactions; Histamine release; Mast cells

Indexed keywords

CONTRAST MEDIUM; LEVOMETHADONE; MEGLUMINE DIATRIZOATE; MEGLUMINE IOGLICATE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; MEGLUMINE IOXITALAMATE PLUS SODIUM IOXITALAMATE; OPIATE; PETHIDINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL SUSPENSION; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; FEMALE; FLUOROMETRY; HEART MUSCLE CELL; HISTAMINE RELEASE; IN VITRO STUDY; KIDNEY CELL; LUNG ALVEOLUS CELL; MALE; MAST CELL; NONHUMAN; PERITONEUM LAVAGE; PROTEIN ANALYSIS; RAT; SWINE;

EID: 4344588179     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-004-0358-1     Document Type: Article

References (21)

1. Ennis M. Laboratory histamine measurements to study Type I adverse allergic/pseudoallergic reactions to agents used in anaesthesia and surgery. Monogr Allergy 1992; 30: 4-93.
2. Lorenz W, Neugebauer E. Fluorometric assays. Handb Exp Pharmacol 1991; 97: 81-92.
3. Lorenz W, Duda D, Dick W, Sitter H, Doenicke A, Black A et al. The incidence and clinical importance of perioperative histamine release: the effects of volume loading and antihistaminics after induction of anaesthesia. Lancet 1994; 343: 933-40.
4. Celik I, Duda D, Stinner B, Kimura K, Gajek H, Lorenz W. Early and late histamine release induced by albumin, hetastarch and polygeline: some unexpected findings. Inflamm Res 2003; 52: 408-16.
5. Lorenz W, Schmal A, Schult H, Lang S, Ohmann C, Weber D et al. Histamine release and hypotensive reactions in dogs by solubilizing agents and fatty acids: analysis of various components in cremophor E1 and development of a compound with reduced toxicity. Agents Actions 1982; 12: 64-80.
6. Celik I, Lorenz W, Stinner B, Duda D, Sitter H, Sauer S et al. Clinic modelling randomised trials (CMRT's) in animals as a new intermediate between biological experiments and randomised clinical trials: application to antihistamine prophylaxis in anaesthesia and surgery. Inflamm Res 1998; 47 Suppl 1: S66-8.
7. Ennis M, Schneider C, Nehring E, Lorenz W. Histamine release induced by opioid analgesics: A comparative study using porcine mast cells. Agents Actions 1991; 33: 20-2.
8. Ennis M, Lorenz W, Nehring E, Schneider C. In vitro and in vivo studies of radiographic contrast media-induced histamine release in pigs. Agents Actions 1991; 33: 26-9.
9. Ennis M. Histamine release from human pulmonary mast cells. Agents Actions 1981; 12: 60-3.
10. Atkinson G, Ennis M, Pearce FL. The effect of alkaline earth cations on the release of histamine from rat peritoneal cells with compound 48/80 and peptide 401. Br J Pharmacol 1979; 65: 395-402.
11. Ennis M. Histamine determination: current techniques. Automated fluoromerric assays. Handb Exp Pharmacol 1991; 97: 31-8.
12. Rodriguez RM, Gueant JL, Gastin IA, Angioi M, Abdelmoutaleb I, Saint-Laudy J et al. Comparison of effects of ioxaglate versus iomeprol on histamine and tryptase release in patients with ischemic cardiomyopathy. Am J Cardiol 2001; 88: 185-8.
13. Rodriguez RM, Gueant JL, Aimone-Gastin I, Gerard P, Amoghly F, Bellou A et al. The increased histamine release in ischaemic heart disease patients undergoing coronaroangiography is not mediated by specific IgE. Allergy 2002; 57 Suppl 72: 61-6.
14. Stellato C, de Crescenzo G, Patella V, Mastronardi P, Mazzarella B, Marone G. Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator release. J Allergy Clin Immunol 1996; 97: 838-50.
15. Forsythe P, Ennis M. Clinical consequences of mast cell heterogeneity. Inflammation Res 2000; 49: 147-54.
16. Celik I, Hoppe M, Lorenz W, Sitter H, Ishaque N, Jungraithmayr W et al. Randomized study comparing a non-ionic with an ionic contrast medium in patients with malignancies: first answer with a new diagnostic approach. Inflamm Res 1999; 48 Suppl 1: S47-8.
17. Lowmann MA, Rees PH, Benyon RC, Church MK. Human mast cell heterogeneity: Histamine release from mast cells dispersed from skin, lung adenoids tonsils and colon in response to IgE-dependent and non-immunological stimuli. J Allergy Clin Immunol 1988; 81: 590-7.
18. Tharp MD, Kagey-Sobotka A, Fox CC, Marone G, Lichtenstein LM, Sullivan TJ. Functional heterogeneity of human mast cells from different anatomic sites: In vitro responses to morphine sulphate. J Allergy Clin Immunol 1987; 79: 646-53.
19. Stellato C, Cirillo R, de Paulis A, Casolaro V, Patella V, Mastronardi P et al. Human basophil/mast cell releasability. IX Heterogeneity of the effects of opioids on mediator release. Anesthesiology 1992; 77: 932-40.
20. Benyon RC, Robinson C, Church MK. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE dependent and non-immunological stimuli. Br J Pharmacol 1989; 97: 898-904.
21. Grosman N. Histamine release from isolated rat mast cells: effect of morphine and related drugs and their interaction with compound 48/80. Agents Actions 1981; 11: 196-203.